ERBB2 and breast cancer: Triple-negative breast cancers (TNBCs) are a clinically relevant subtype of breast cancer encompassing tumors that lack expression of the estrogen receptor (ER), progesterone receptor, and human epithelial growth factor receptor 2 (HER2) (1, 2).